UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone

Cancer cell, 2015-06, Vol.27 (6), p.809-821

2015

Volltextzugriff (PDF)

TGF-β-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases

Cancer research (Chicago, Ill.), 2011-01, Vol.71 (1), p.175-184

2011

Volltextzugriff (PDF)

Molecular Biology of Bone Metastasis

Molecular cancer therapeutics, 2007-10, Vol.6 (10), p.2609-2617

2007

Volltextzugriff (PDF)

Halofuginone Inhibits the Establishment and Progression of Melanoma Bone Metastases

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (23), p.6247-6256

2012

Volltextzugriff (PDF)

Bisphosphonates and cancer-induced bone disease : Beyond their antiresorptive activity

Cancer research (Chicago, Ill.), 2005-06, Vol.65 (12), p.4971-4974

2005

Volltextzugriff (PDF)

Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice

Journal of bone and mineral research, 2022-08, Vol.37 (8), p.1446-1463

2022

Volltextzugriff (PDF)

Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment

PloS one, 2009-09, Vol.4 (9), p.e6896

2009

Volltextzugriff (PDF)

Contribution of Macrophages and T Cells in Skeletal Metastasis

Cancers, 2020-04, Vol.12 (4), p.1014

2020

Volltextzugriff (PDF)

Functionalized rare earth-doped nanoparticles for breast cancer nanodiagnostic using fluorescence and CT imaging

Journal of nanobiotechnology, 2018-03, Vol.16 (1), p.26-18, Article 26

2018

Volltextzugriff (PDF)

Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy

Journal of nanobiotechnology, 2018-02, Vol.16 (1), p.19-19, Article 19

2018

Volltextzugriff (PDF)

Brome mosaic virus-like particles as siRNA nanocarriers for biomedical purposes

Beilstein journal of nanotechnology, 2020-02, Vol.11 (1), p.372-382

2020

Volltextzugriff (PDF)

Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis

Oncotarget, 2017-10, Vol.8 (49), p.86447-86462

2017

Volltextzugriff (PDF)

TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases

Cancers, 2020-04, Vol.12 (4), p.868

2020

Volltextzugriff (PDF)

GLI2-Mediated Melanoma Invasion and Metastasis

JNCI : Journal of the National Cancer Institute, 2010-08, Vol.102 (15), p.1148-1159

2010

Volltextzugriff (PDF)

Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase

Bone (New York, N.Y.), 2011-02, Vol.48 (2), p.259-266

2011

Volltextzugriff (PDF)

The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm

Oncotarget, 2017-04, Vol.8 (16), p.26687-26701

2017

Volltextzugriff (PDF)

How Do Bisphosphonates Inhibit Bone Metastasis In Vivo

Neoplasia (New York, N.Y.), 2010-07, Vol.12 (7), p.571-578

2010

Volltextzugriff (PDF)

Monocytic Myeloid-Derived Suppressor Cells from Tumor Tissue Are a Differentiated Cell with Limited Fate Plasticity

ImmunoHorizons, 2022-12, Vol.6 (12), p.790-806

2022

Volltextzugriff (PDF)

Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo

Cancer research (Chicago, Ill.), 2008-11, Vol.68 (21), p.8945-8953

2008

Volltextzugriff (PDF)

Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (5), p.2317-2324

2007

Volltextzugriff (PDF)

In silico-designed mutations increase variable new-antigen receptor single-domain antibodies for VEGF165 neutralization

Oncotarget, 2018-06, Vol.9 (46), p.28016-28029

2018

Volltextzugriff (PDF)

FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells

Oncotarget, 2015-08, Vol.6 (23), p.19647-19660

2015

Volltextzugriff (PDF)

New insights into the role of T cells in the vicious cycle of bone metastases

Current opinion in rheumatology, 2006-07, Vol.18 (4), p.396-404

2006

Volltextzugriff (PDF)

In vitro and in vivo antitumor effects of bisphosphonates

Current medicinal chemistry, 2003-01, Vol.10 (2), p.173

2003

Volltextzugriff (PDF)

Angiostatin Inhibits Bone Metastasis Formation in Nude Mice through a Direct Anti-osteoclastic Activity

The Journal of biological chemistry, 2003-11, Vol.278 (46), p.45826-45832

2003

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone

TGF-β-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases

Molecular Biology of Bone Metastasis

Halofuginone Inhibits the Establishment and Progression of Melanoma Bone Metastases

Bisphosphonates and cancer-induced bone disease : Beyond their antiresorptive activity

Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice

Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment

Contribution of Macrophages and T Cells in Skeletal Metastasis

Functionalized rare earth-doped nanoparticles for breast cancer nanodiagnostic using fluorescence and CT imaging

Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy

Brome mosaic virus-like particles as siRNA nanocarriers for biomedical purposes

Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis

TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases

GLI2-Mediated Melanoma Invasion and Metastasis

Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase

The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm

How Do Bisphosphonates Inhibit Bone Metastasis In Vivo

Monocytic Myeloid-Derived Suppressor Cells from Tumor Tissue Are a Differentiated Cell with Limited Fate Plasticity

Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo

Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis

In silico-designed mutations increase variable new-antigen receptor single-domain antibodies for VEGF165 neutralization

FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells

New insights into the role of T cells in the vicious cycle of bone metastases

In vitro and in vivo antitumor effects of bisphosphonates

Angiostatin Inhibits Bone Metastasis Formation in Nude Mice through a Direct Anti-osteoclastic Activity

Suchergebnisse filtern